AAAAAA
Results:
1-15
|
Results: 15
Authors:
Jernstrom, H
Vesprini, D
Bradlow, HL
Narod, SA
Citation: H. Jernstrom et al., Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years, J NAT CANC, 93(7), 2001, pp. 554-555
Authors:
Bradlow, HL
Citation: Hl. Bradlow, Feeding DHEA to C57BL/6 mice (vol 224, pg 201, 2000), EXP BIOL ME, 226(3), 2001, pp. 237-237
Authors:
Riza, E
Silva, ID
De Stavola, B
Bradlow, HL
Sepkovic, DW
Linos, D
Linos, A
Citation: E. Riza et al., Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women, CANC EPID B, 10(6), 2001, pp. 627-634
Authors:
Yoo, HJ
Sepkovic, DW
Bradlow, HL
Yu, GP
Sirilian, HV
Schantz, SP
Citation: Hj. Yoo et al., Estrogen metabolism as a risk factor for head and neck cancer, OTO H N SUR, 124(3), 2001, pp. 241-247
Authors:
Weyant, MJ
Carothers, AM
Mahmoud, NN
Bradlow, HL
Remotti, H
Bilinski, RT
Bertagnolli, MM
Citation: Mj. Weyant et al., Reciprocal expression of ER alpha and ER beta is associated with estrogen-mediated modulation of intestinal tumorigenesis, CANCER RES, 61(6), 2001, pp. 2547-2551
Authors:
Telang, NT
Katdare, M
Bradlow, HL
Osborne, MP
Citation: Nt. Telang et al., Cell cycle regulation, apoptosis and estradiol biotransformation: Novel endpoint biomarkers for human breast cancer prevention, J CLIN LIG, 23(2), 2000, pp. 130-137
Authors:
Falk, RT
Rossi, SC
Fears, TR
Sepkovic, DW
Migella, A
Adlercreutz, H
Donaldson, J
Bradlow, HL
Ziegler, RG
Citation: Rt. Falk et al., A new ELISA kit for measuring urinary 2-hydroxyestrone, 16 alpha-hydroxyestrone, and their ratio: Reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid, CANC EPID B, 9(1), 2000, pp. 81-87
Authors:
Muti, P
Bradlow, HL
Micheli, A
Krogh, V
Freudenheim, JL
Schunemann, HJ
Stanulla, M
Yang, J
Sepkovic, DW
Trevisan, M
Berrino, F
Citation: P. Muti et al., Estrogen metabolism and risk of breast cancer: A prospective study of the 2 : 16 alpha-hydroxyestrone ratio in premenopausal and postmenopausal women, EPIDEMIOLOG, 11(6), 2000, pp. 635-640
Authors:
Bell, MC
Crowley-Nowick, P
Bradlow, HL
Sepkovic, DW
Schmidt-Grimminger, D
Howell, P
Mayeaux, EJ
Tucker, A
Turbat-Herrera, EA
Mathis, JM
Citation: Mc. Bell et al., Placebo-controlled trial of indole-3-carbinol in the treatment of CIN, GYNECOL ONC, 78(2), 2000, pp. 123-129
Authors:
Bradlow, HL
Citation: Hl. Bradlow, Comment - Feeding DHEA to C57/B167 mice, P SOC EXP M, 224(4), 2000, pp. 201-201
Authors:
Michaud, DS
Manson, JE
Spiegelman, D
Barbieri, RL
Sepkovic, DW
Bradlow, HL
Hankinson, SE
Citation: Ds. Michaud et al., Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period, CANC EPID B, 8(12), 1999, pp. 1059-1064
Authors:
Taioli, E
Bradlow, HL
Garbers, SV
Sepkovic, DW
Osborne, MP
Trachman, J
Ganguly, S
Garte, SJ
Citation: E. Taioli et al., Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk, CANCER DET, 23(3), 1999, pp. 232-237
Authors:
Singhal, H
Guo, L
Bradlow, HL
Mittelman, A
Tiwari, RK
Citation: H. Singhal et al., Endocrine characteristics of human breast epithelial cells, MCF-10F, HORMONE RES, 52(4), 1999, pp. 171-177
Authors:
Yuan, F
Chen, DZ
Liu, K
Sepkovic, DW
Bradlow, HL
Auborn, K
Citation: F. Yuan et al., Anti-estrogenic activities of indole-3-carbinol in cervical cells: Implication for prevention of cervical cancer, ANTICANC R, 19(3A), 1999, pp. 1673-1680
Authors:
Auborn, K
Abramson, A
Bradlow, HL
Sepkovic, D
Mullooly, V
Citation: K. Auborn et al., Estrogen metabolism and laryngeal papillomatosis: A pilot study on dietaryprevention, ANTICANC R, 18(6B), 1998, pp. 4569-4573
Risultati:
1-15
|